Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
McKinsey
Johnson and Johnson
Colorcon
McKesson

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Ranitidine - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

Recent Clinical Trials for ranitidine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Sao Paulo General HospitalPhase 3
Ohio State University Comprehensive Cancer CenterPhase 2/Phase 3
Ain Shams UniversityPhase 4

See all ranitidine clinical trials

Generic filers with tentative approvals for RANITIDINE
Applicant Application No. Strength Dosage Form
⤷  Try it Free⤷  Try it Free15MG/MLSolution; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for ranitidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Us ZANTAC 150 ranitidine hydrochloride TABLET;ORAL 021698-001 Aug 31, 2004 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Vkt Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 211289-002 Jan 31, 2019 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sun Pharm Inds Ltd RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075439-002 Apr 19, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Strides Pharma RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 200536-001 Jun 28, 2011 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Wockhardt Ltd RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075208-001 Dec 17, 1998 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Par Pharm RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 075180-001 Jan 28, 1999 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Glaxo Grp Ltd ZANTAC 150 ranitidine hydrochloride TABLET, EFFERVESCENT;ORAL 020251-001 Mar 31, 1994 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.